Search

Your search keyword '"Chan, Pui Ying"' showing total 134 results

Search Constraints

Start Over You searched for: Author "Chan, Pui Ying" Remove constraint Author: "Chan, Pui Ying"
134 results on '"Chan, Pui Ying"'

Search Results

1. Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA

4. COVID-19 Outbreak — New York City, February 29–June 1, 2020

7. Supplementary materials and methods from The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis

8. Table S1-S7 from The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis

9. Figure S1-S3 from The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis

12. A Phase 1 study ofADI‐PEG20(pegargiminase) combined with cisplatin and pemetrexed inASS1‐negativemetastatic uveal melanoma

15. Early intervention and special education in New York City: Patterns of service use and disparities affecting children of colour.

18. Phase 1, pharmacogenomic, dose‐expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1‐deficient non‐squamous non‐small cell lung cancer

20. A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma.

22. ctDNA monitoring using patient-specific sequencing and integration of variant reads

25. Noninvasive Detection of Clinically Significant Prostate Cancer Using Circulating Tumor Cells

26. Reply by Authors

30. High-sensitivity monitoring of ctDNA by patient-specific sequencing panels and integration of variant reads

31. Phase 1 dose-expansion study of pegylated arginine deiminase, cisplatin, and pemetrexed in patients with argininosuccinate synthetase 1 (ASS1)–deficient non-squamous non-small cell lung cancer.

33. Birth characteristics of children who used early intervention and special education services in New York City.

34. Phase 1 study of pegargiminase combined with cisplatin and pemetrexed in patients with ASS1-deficient uveal melanoma.

37. Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma

38. The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis

40. Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1–Deficient Thoracic Cancers

45. Results of the first thousand patients from a multidisciplinary prostate cancer clinic.

49. Abstract B23: A phase 1 study in patients with mesothelioma or non small cell lung tumours requiring arginine to assess ADI-PEG 20 with pemetrexed and cisplatin (TRAP study)

Catalog

Books, media, physical & digital resources